Nearly 40% of participants lost more than 25% of their body weight (Jastreboff et al., New England Journal of Medicine , 2022) SURMOUNT-2: In patients with type 2 diabetes and obesity, tirzepatide 15 mg produced 14.7% weight loss over 72 weeks (Garvey et al., Lancet , 2023) SURMOUNT-3: When added to an intensive lifestyle intervention, tirzepatide produced an additional 18.4% weight loss beyond what lifestyle changes alone achieved These results represent the most substantial weight loss outcomes ever achieved with a pharmaceutical intervention in clinical trials

BPC-157 has been widely studied in preclinical models for its potential role in: Tissue regeneration research (muscle, tendon, and epithelial cells), Gastrointestinal studies, exploring protective effects on gut lining and gastric integrity, ,Angiogenesis and vascular modulation research, Neuroprotective and anti-inflammatory investigations These findings support continued interest in understanding BPC-157s interaction with cellular growth and repair pathways in experimental contexts
doi: 10.1186/1471-2164-7-184 170 EumJHSeoYRYoeSMKangSWHanSS
A Note From EarthChimp A plant-based option like EarthChimp offers a gentle protein source that blends easily with water or light mixes